Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Majid Ghareghani

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|July 14, 2023
The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer's Disease TreatmentMajid Ghareghani, Serge Rivest
Brain : a Journal of Neurology|November 20, 2025
Routes of precursors' migration in remyelinationMajid Ghareghani, Samira Ghorbani
Journal of Personalized Medicine|February 23, 2024
Multiple Sclerosis Research Evolves: A Closer Look at Deep Gray Matter, Sexual Function Rehabilitation, and T Regulatory CellsMajid Ghareghani, Serge Rivest
Frontiers in Cellular Neuroscience|September 16, 2024
The evolution of mesenchymal stem cell-derived neural progenitor therapy for Multiple Sclerosis: from concept to clinicMajid Ghareghani, Ayanna Arneaud, Serge Rivest
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2023
Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosisMajid Ghareghani, Kazem Zibara, Serge Rivest
Cellular and Molecular Neurobiology|March 3, 2018
Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple SclerosisMajid Ghareghani, Kazem Zibara, Hossein Sadeghi, et al.
Frontiers in Immunology|March 31, 2022
PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple SclerosisMajid Ghareghani, Zahra Farhadi, Serge Rivest, et al.
BMC Neurology|July 28, 2023
Where do we look for the next breakthrough in sleep research?Alessandro Viganò, Majid Ghareghani, Birendra Mallick, et al.
Expert Reviews in Molecular Medicine|May 16, 2022
Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zoneMajid Ghareghani, Kazem Zibara, Russel J Reiter, et al.
Frontiers in Immunology|November 22, 2018
Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic PathwayMajid Ghareghani, Russel J Reiter, Kazem Zibara, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|July 14, 2023
The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer's Disease TreatmentMajid Ghareghani, Serge Rivest
Brain : a Journal of Neurology|November 20, 2025
Routes of precursors' migration in remyelinationMajid Ghareghani, Samira Ghorbani
Journal of Personalized Medicine|February 23, 2024
Multiple Sclerosis Research Evolves: A Closer Look at Deep Gray Matter, Sexual Function Rehabilitation, and T Regulatory CellsMajid Ghareghani, Serge Rivest
Frontiers in Cellular Neuroscience|September 16, 2024
The evolution of mesenchymal stem cell-derived neural progenitor therapy for Multiple Sclerosis: from concept to clinicMajid Ghareghani, Ayanna Arneaud, Serge Rivest
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2023
Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosisMajid Ghareghani, Kazem Zibara, Serge Rivest
Cellular and Molecular Neurobiology|March 3, 2018
Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple SclerosisMajid Ghareghani, Kazem Zibara, Hossein Sadeghi, et al.
Frontiers in Immunology|March 31, 2022
PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple SclerosisMajid Ghareghani, Zahra Farhadi, Serge Rivest, et al.
BMC Neurology|July 28, 2023
Where do we look for the next breakthrough in sleep research?Alessandro Viganò, Majid Ghareghani, Birendra Mallick, et al.
Expert Reviews in Molecular Medicine|May 16, 2022
Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zoneMajid Ghareghani, Kazem Zibara, Russel J Reiter, et al.
Frontiers in Immunology|November 22, 2018
Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic PathwayMajid Ghareghani, Russel J Reiter, Kazem Zibara, et al.
Pageof 3